DRTSW — Alpha Tau Medical Ltd.

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Chart, dilution, float and news for DRTSW in the TickerWise workspace.

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, lung, and prostate cancers. The company was founded in 2015 and is headquartered in Jerusalem, Israel.

Company profile

• Sector: Healthcare
• Industry: Biotechnology
• Country: IL
• Exchange: NASDAQ
• Employees: 125
• Website: https://www.alphatau.com

Latest SEC filings for DRTSW

• 2026-10-226-K
• 2026-10-196-K
• 2026-08-316-K
• 2026-08-106-K
• 2026-07-216-K
• 2026-07-156-K
• 2026-06-256-K
• 2026-06-236-K
• 2026-06-116-K
• 2026-06-036-K

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Educational tool only — not investment advice.